Relay Therapeutics (RLAY) Short Interest Ratio & Short Volume $2.72 -0.27 (-9.03%) Closing price 04:00 PM EasternExtended Trading$2.76 +0.04 (+1.47%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Relay Therapeutics Short Interest DataRelay Therapeutics (RLAY) has a short interest of 19.12 million shares, representing 11.94% of the float (the number of shares available for trading by the public). This marks a 18.10% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.2, indicating that it would take 8.2 days of the average trading volume of 1.86 million shares to cover all short positions.Current Short Interest19,120,000 sharesPrevious Short Interest16,190,000 sharesChange Vs. Previous Month+18.10%Dollar Volume Sold Short$69.98 millionShort Interest Ratio8.2 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares169,522,000 sharesShort Percent of Float11.94%Today's Trading Volume2,928,427 sharesAverage Trading Volume1,859,103 sharesToday's Volume Vs. Average158% Short Selling Relay Therapeutics? Sign up to receive the latest short interest report for Relay Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRLAY Short Interest Over TimeRLAY Days to Cover Over TimeRLAY Percentage of Float Shorted Over Time Remove Ads Relay Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202519,120,000 shares $69.98 million +18.1%11.9%8.2 $3.66 2/28/202516,190,000 shares $55.21 million +2.5%10.1%6.8 $3.41 2/15/202515,790,000 shares $63.16 million +0.8%9.9%6.8 $4.00 1/31/202515,660,000 shares $70.00 million +3.0%N/A6.8 $4.47 1/15/202515,210,000 shares $57.95 million +1.7%N/A6.6 $3.81 12/31/202414,950,000 shares $61.59 million +23.8%N/A7.2 $4.12 12/15/202412,080,000 shares $56.90 million +1.3%N/A6.2 $4.71 11/30/202411,930,000 shares $56.07 million +2.8%N/A5.7 $4.70 11/15/202411,610,000 shares $59.27 million -3.6%N/A5.4 $5.11 10/31/202412,040,000 shares $67.85 million +1.5%N/A6.1 $5.64 Get the Latest News and Ratings for RLAY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/202411,860,000 shares $79.94 million -4.1%N/A6.2 $6.74 9/30/202412,370,000 shares $87.58 million +24.7%N/A6.5 $7.08 9/15/20249,920,000 shares $75.39 million +9.4%N/A5.4 $7.60 8/31/20249,070,000 shares $61.59 million +0.2%N/A5.2 $6.79 8/15/20249,050,000 shares $60.36 million +2.6%N/A7.4 $6.67 7/31/20248,820,000 shares $72.50 million +4.6%N/A6.5 $8.22 7/15/20248,430,000 shares $69.72 million +4.7%N/A6.2 $8.27 6/30/20248,050,000 shares $52.49 million -18.3%N/A6.1 $6.52 6/15/20249,850,000 shares $72.00 million +2.6%N/A7.5 $7.31 5/31/20249,600,000 shares $61.54 million -19.3%N/A7.3 $6.41 5/15/202411,890,000 shares $80.79 million +3.1%N/A9.5 $6.80 4/30/202411,530,000 shares $75.18 million +7.9%N/A9.4 $6.52 4/15/202410,690,000 shares $73.01 million -4.3%N/A9 $6.83 3/31/202411,170,000 shares $92.71 million -5.4%N/A10 $8.30 3/15/202411,810,000 shares $93.89 million +7.4%N/A10.9 $7.95 2/29/202411,000,000 shares $110.22 million +12.1%N/A10.5 $10.02 2/15/20249,810,000 shares $104.67 million +3.8%N/A9.2 $10.67 1/31/20249,450,000 shares $87.41 million -16.3%11.0%9.5 $9.25 1/15/202411,290,000 shares $124.19 million -6.0%13.1%10.3 $11.00 12/31/202312,010,000 shares $132.23 million -12.3%14.1%10.4 $11.01 12/15/202313,700,000 shares $138.92 million -6.4%16.1%11.5 $10.14 11/30/202314,630,000 shares $115.72 million -0.1%17.3%12.1 $7.91 11/15/202314,640,000 shares $125.17 million +1.5%17.3%12.7 $8.55 10/31/202314,430,000 shares $95.24 million +4.8%16.9%12.9 $6.60 10/15/202313,770,000 shares $106.58 million -29.0%16.3%13.5 $7.74 9/30/202319,400,000 shares $163.15 million -3.4%22.9%19.9 $8.41 9/15/202320,080,000 shares $188.15 million +1.0%23.7%21 $9.37 8/31/202319,890,000 shares $203.28 million -3.9%23.5%19.1 $10.22 8/15/202320,700,000 shares $219.83 million +5.5%24.5%18.3 $10.62 7/31/202319,630,000 shares $247.34 million -1.1%23.3%16.4 $12.60The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 7/15/202319,840,000 shares $242.64 million -3.1%23.8%14.7 $12.23 6/30/202320,480,000 shares $257.23 million -2.9%24.6%12.1 $12.56 6/15/202321,080,000 shares $269.61 million -0.4%25.3%12.3 $12.79 5/31/202321,160,000 shares $235.72 million -1.5%25.4%13.1 $11.14 5/15/202321,480,000 shares $221.03 million +8.5%25.8%13.6 $10.29 4/30/202319,800,000 shares $225.13 million +1.4%23.4%13 $11.37 4/15/202319,530,000 shares $340.60 million +3.3%23.1%13.3 $17.44 3/31/202318,910,000 shares $311.45 million +5.5%22.4%15.4 $16.47 3/15/202317,930,000 shares $295.85 million +0.8%21.3%13.8 $16.50 2/28/202317,780,000 shares $287.15 million +3.0%21.1%13 $16.15 2/15/202317,270,000 shares $317.25 million -0.6%20.6%12.9 $18.37 1/31/202317,380,000 shares $372.97 million -6.9%20.7%13 $21.46 1/15/202318,660,000 shares $387.57 million +10.5%22.2%14.7 $20.77 12/30/202216,890,000 shares $252.34 million +25.8%20.0%13.8 $14.94 12/15/202213,430,000 shares $230.59 million +7.5%15.9%12.2 $17.17 11/30/202212,490,000 shares $232.06 million -4.3%14.8%11.1 $18.58 11/15/202213,050,000 shares $258.39 million -3.1%15.4%10.5 $19.80 10/31/202213,460,000 shares $299.08 million +3.1%16.5%10.9 $22.22 10/15/202213,060,000 shares $254.80 million +7.2%16.1%10.4 $19.51 9/30/202212,180,000 shares $272.47 million +4.0%15.0%10.2 $22.37 9/15/202211,710,000 shares $293.69 million -25.0%15.9%9.2 $25.08 8/31/202215,620,000 shares $358.79 million -15.2%21.2%13.4 $22.97 8/15/202218,420,000 shares $386.27 million -1.8%25.1%18.1 $20.97 7/31/202218,760,000 shares $356.82 million -1.4%25.6%17.4 $19.02 7/15/202219,020,000 shares $368.99 million -6.8%26.0%17.9 $19.40 6/30/202220,410,000 shares $341.87 million +11.2%27.9%20.2 $16.75 6/15/202218,360,000 shares $263.10 million +2.5%25.1%19.2 $14.33 5/31/202217,920,000 shares $291.74 million +9.6%24.5%23.3 $16.28 5/15/202216,350,000 shares $287.43 million +11.7%22.3%21.9 $17.58 4/30/202214,640,000 shares $348.87 million +2.0%19.9%22.2 $23.83 4/15/202214,360,000 shares $441.43 million -1.8%19.6%22.8 $30.74 3/31/202214,620,000 shares $437.58 million -8.9%19.9%22.6 $29.93 3/15/202216,050,000 shares $367.87 million +4.4%21.9%26.4 $22.92 2/28/202215,380,000 shares $370.81 million +2.1%21.0%26.1 $24.11 2/15/202215,070,000 shares $323.25 million +1.3%21.6%25.1 $21.45 1/31/202214,880,000 shares $329.29 million +7.5%21.1%26.3 $22.13 1/15/202213,840,000 shares $363.85 million +1.1%22.2%25.8 $26.29 12/31/202113,690,000 shares $420.42 million -3.9%21.9%19 $30.71 12/15/202114,250,000 shares $414.11 million +3.3%22.8%17.7 $29.06 11/30/202113,790,000 shares $405.70 million +2.6%22.3%16.5 $29.42 11/15/202113,440,000 shares $474.70 million +6.6%21.8%15.8 $35.32 10/29/202112,610,000 shares $419.28 million -1.3%22.5%14.5 $33.25 10/15/202112,770,000 shares $435.58 million +21.0%22.8%15.3 $34.11 9/30/202110,550,000 shares $332.64 million +5.5%18.8%16.8 $31.53 9/15/202110,000,000 shares $369.30 million -3.3%17.8%17.8 $36.93 8/31/202110,340,000 shares $331.19 million -1.0%18.5%20 $32.03 8/13/202110,440,000 shares $344.83 million +6.1%18.7%21 $33.03 7/30/20219,840,000 shares $319.21 million +7.3%18.8%21 $32.44 7/15/20219,170,000 shares $292.16 million +2.2%17.2%17.4 $31.86 6/30/20218,970,000 shares $328.21 million +7.0%17.1%16.3 $36.59The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 6/15/20218,380,000 shares $287.10 million -3.6%15.9%14.6 $34.26 5/28/20218,690,000 shares $279.12 million +4.1%16.5%13.5 $32.12 5/14/20218,350,000 shares $229.63 million +0.2%15.9%12.3 $27.50 4/30/20218,330,000 shares $277.39 million +10.0%18.5%11.5 $33.30 4/15/20217,570,000 shares $257.76 million -7.5%16.8%11.2 $34.05 3/31/20218,180,000 shares $291.04 million +23.2%18.2%10.2 $35.58 3/15/20216,640,000 shares $260.89 million +4.1%14.8%8.7 $39.29 2/26/20216,380,000 shares $270.00 million +20.2%14.3%9.9 $42.32 2/12/20215,310,000 shares $245.48 million -2.9%11.9%9 $46.23 1/29/20215,470,000 shares $291.00 million -18.6%12.1%10.4 $53.20 1/15/20216,720,000 shares $294.13 million No Change14.9%13.8 $43.77 RLAY Short Interest - Frequently Asked Questions What is Relay Therapeutics' current short interest? Short interest is the volume of Relay Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 19,120,000 shares of RLAY short. 11.94% of Relay Therapeutics' shares are currently sold short. Learn More on Relay Therapeutics' current short interest. What is a good short interest ratio for Relay Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLAY shares currently have a short interest ratio of 8.0. Learn More on Relay Therapeutics's short interest ratio. Which institutional investors are shorting Relay Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Relay Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Relay Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.94% of Relay Therapeutics' floating shares are currently sold short. Is Relay Therapeutics' short interest increasing or decreasing? Relay Therapeutics saw a increase in short interest in March. As of March 15th, there was short interest totaling 19,120,000 shares, an increase of 18.1% from the previous total of 16,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Relay Therapeutics' short interest compare to its competitors? 11.94% of Relay Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Relay Therapeutics: Vericel Co. (7.59%), Centessa Pharmaceuticals plc (6.05%), Denali Therapeutics Inc. (8.36%), Kymera Therapeutics, Inc. (14.38%), Mirum Pharmaceuticals, Inc. (16.96%), Belite Bio, Inc (0.32%), Arrowhead Pharmaceuticals, Inc. (8.65%), CG Oncology, Inc. (15.58%), Harmony Biosciences Holdings, Inc. (9.45%), Arcutis Biotherapeutics, Inc. (14.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Relay Therapeutics stock? Short selling RLAY is an investing strategy that aims to generate trading profit from Relay Therapeutics as its price is falling. RLAY shares are trading down $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relay Therapeutics? A short squeeze for Relay Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RLAY, which in turn drives the price of the stock up even further. How often is Relay Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLAY, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies VCEL Short Squeeze CNTA Short Squeeze DNLI Short Squeeze KYMR Short Squeeze MIRM Short Squeeze BLTE Short Squeeze ARWR Short Squeeze CGON Short Squeeze HRMY Short Squeeze ARQT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLAY) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RLAY Stock Free RLAY Stock Alerts